Filtered By:
Source: Current Alzheimer Research
Condition: Alzheimer's
This page shows you your search results in order of date.
Order by Relevance | Date
Total 33 results found since Jan 2013.
Cytokine storm and neuropathological alterations in patients with neurological manifestations of COVID-19
Curr Alzheimer Res. 2022 Sep 8. doi: 10.2174/1567205019666220908084559. Online ahead of print.ABSTRACTThe COVID-19 pandemic is caused by the severe acute respiratory syndrome coronavirus (SARS-CoV-2), a respiratory pathogen with neuroinvasive potential. Neurological COVID-19 manifestations include loss of smell and taste, headache, dizziness, stroke, and potentially fatal encephalitis. Several studies found elevated proinflammatory cytokines such as TNF-α, IFN-γ, IL-6 IL-8, IL-10 IL-16, IL-17A, and IL-18 in severely and critically ill COVID-19 patients, which may persist even after apparent recovery from infection. Bioma...
Source: Current Alzheimer Research - September 12, 2022 Category: Neurology Authors: Christos Tsagkaris Muhammad Bilal Irem Aktar Youssef Aboufandi Ahmet Tas Abdullahi Tunde Aborode Tarun Kumar Suvvari Shoaib Ahmad Anastasiia Shkodina Rachana Phadke Marwa S Emhamed Atif Amin Baig Athanasios Alexiou Ghulam Md Ashraf Mohammad Amjad Kamal Source Type: research
Poststroke cognitive impairment: a longitudinal follow-up and pre/poststroke mini-mental state examination comparison
CONCLUSION: Ischemic stroke substantially affects cognition with an average six-point drop in MMSE. The rate of cognitive decline in PSCI was similar to AD, and those with white matter or basal ganglia infarct were at greater risk of PSCI.PMID:35927922 | DOI:10.2174/1567205019666220802151945
Source: Current Alzheimer Research - August 5, 2022 Category: Neurology Authors: Chien-Tai Hong Hsun-Hua Lee Chen-Chih Chung Wei-Ting Chiu Ting-Yi Lee David Yen-Ting Chen Li-Kai Huang Chaur-Jong Hu Lung Chan Source Type: research
